1. Home
  2. BAFN vs BEAT Comparison

BAFN vs BEAT Comparison

Compare BAFN & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

HOLD

Current Price

$7.75

Market Cap

40.6M

Sector

Finance

ML Signal

HOLD

Logo Heartbeam Inc.

BEAT

Heartbeam Inc.

HOLD

Current Price

$2.32

Market Cap

84.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAFN
BEAT
Founded
1999
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
40.6M
84.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BAFN
BEAT
Price
$7.75
$2.32
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.75
AVG Volume (30 Days)
6.7K
32.3M
Earning Date
01-29-2026
11-13-2025
Dividend Yield
2.08%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$58,931,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.40
$0.54
52 Week High
$19.75
$4.00

Technical Indicators

Market Signals
Indicator
BAFN
BEAT
Relative Strength Index (RSI) 34.85 54.71
Support Level $7.80 $2.26
Resistance Level $7.90 $3.18
Average True Range (ATR) 0.17 0.63
MACD 0.01 -0.00
Stochastic Oscillator 10.22 39.81

Price Performance

Historical Comparison
BAFN
BEAT

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Share on Social Networks: